stoxline Quote Chart Rank Option Currency Glossary
  
Boston Scientific Corporation (BSX)
78.59  0.32 (0.41%)    07-23 16:00
Open: 78.56
High: 79.43
Volume: 5,673,570
  
Pre. Close: 78.27
Low: 78.19
Market Cap: 115,541(M)
Technical analysis
2024-07-23 4:50:57 PM
Short term     
Mid term     
Targets 6-month :  92.77 1-year :  108.36
Resists First :  79.43 Second :  92.77
Pivot price 77.12
Supports First :  76.16 Second :  74.15
MAs MA(5) :  77.47 MA(20) :  77.09
MA(100) :  72.58 MA(250) :  62.35
MACD MACD :  0.5 Signal :  0.4
%K %D K(14,3) :  79.9 D(3) :  64
RSI RSI(14): 60.3
52-week High :  79.43 Low :  48.34
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ BSX ] has closed below upper band by 8.6%. Bollinger Bands are 5.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 79.55 - 79.87 79.87 - 80.2
Low: 77.4 - 77.73 77.73 - 78.08
Close: 78.05 - 78.62 78.62 - 79.22
Company Description

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Headline News

Tue, 23 Jul 2024
O Shaughnessy Asset Management LLC Grows Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat

Tue, 23 Jul 2024
Watchman In Focus As Boston Scientific Reports Its Q2 - Forbes

Tue, 23 Jul 2024
Boston Scientific Co. (NYSE:BSX) Stock Position Raised by Blair William & Co. IL - Defense World

Mon, 22 Jul 2024
Boston Scientific (BSX) Banks on Global Expansion, Innovation - Yahoo Finance

Mon, 22 Jul 2024
Orion Portfolio Solutions LLC Sells 727 Shares of Boston Scientific Co. (NYSE:BSX) - Defense World

Sun, 21 Jul 2024
Boston Scientific (NYSE:BSX) shareholders have earned a 13% CAGR over the last five years - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 1,470 (M)
Shares Float 1,470 (M)
Held by Insiders 0.1 (%)
Held by Institutions 92.7 (%)
Shares Short 11,250 (K)
Shares Short P.Month 13,380 (K)
Stock Financials
EPS 1.19
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 13.56
Profit Margin 12 %
Operating Margin 17.9 %
Return on Assets (ttm) 4.5 %
Return on Equity (ttm) 9.2 %
Qtrly Rev. Growth 13.8 %
Gross Profit (p.s.) 0
Sales Per Share 10
EBITDA (p.s.) 2.54
Qtrly Earnings Growth 57.9 %
Operating Cash Flow 2,480 (M)
Levered Free Cash Flow 1,650 (M)
Stock Valuations
PE Ratio 66.04
PEG Ratio 2.6
Price to Book value 5.79
Price to Sales 7.85
Price to Cash Flow 46.58
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android